| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/29/2007 | EP1825861A2 Anti-inflammatory extract and agent and method for the production thereof |
| 08/29/2007 | EP1825850A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
| 08/29/2007 | EP1825849A1 Transdermal therapeutic system comprising fentanyl |
| 08/29/2007 | EP1824860A2 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 08/29/2007 | EP1824818A2 2ALFA-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1ALFA-HYDROXYVITAMIN D3 AND THEIR USES |
| 08/29/2007 | EP1824475A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 08/29/2007 | EP1824469A1 A method of modulating b cell functioning |
| 08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
| 08/29/2007 | EP1506167B1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
| 08/29/2007 | EP1441700B1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/29/2007 | EP1414961B1 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 08/29/2007 | EP1404652B1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1259120B1 Method for isolating collagen from marine sponge and producing nanoparticulate collagen, and the use thereof |
| 08/29/2007 | EP1239814B1 Use of the residues from wine production |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1140078B1 Benzimidazole vascular damaging agents |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | CN101027304A Synthesis of 6,7-dihydro-5H-imidazo[1,2-A]imidazole-3-sulfonic acid amides |
| 08/29/2007 | CN101027302A Pyrrolo-pyridine kinase modulators |
| 08/29/2007 | CN101027292A Compounds, compositions containing them, preparation thereof and uses thereof |
| 08/29/2007 | CN101027049A A pharmaceutical composition and its use |
| 08/29/2007 | CN101024628A Aza-flavones, its preparing method and use |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101024075A Use of ulinastatin for preparing medicine for treating and protecting multi-organ function injury |
| 08/29/2007 | CN101024065A Huoluoyou medicine composition and preparation method |
| 08/29/2007 | CN101024062A Medicine for treating salpingitis tubal obstruction and preparing method |
| 08/29/2007 | CN101024050A Medicine composition for treating rheumatism and rheumatoid arthritis |
| 08/29/2007 | CN101024047A 3-D incense therapy rod |
| 08/29/2007 | CN101024029A Medicine for treating bony arthritis, rheumatism arthritis |
| 08/29/2007 | CN101024027A Plaster for treating rheumatism bone disease and its preparing |
| 08/29/2007 | CN101024023A Medicine for treating cervical spondylosis |
| 08/29/2007 | CN101024003A Medicine for treating injury and preparing method |
| 08/29/2007 | CN101023996A Chinese medicine for treating exogenous epidemic disease and anemopyretic cold |
| 08/29/2007 | CN101023994A Medicinal liquor for treating rheumatism and rheumatoid diseases |
| 08/29/2007 | CN101023990A Chinese readymade medicine for treating exogenous disease |
| 08/29/2007 | CN101023979A Lamiophlomis-rotata leaf-stem distract and its preparing process and use |
| 08/29/2007 | CN101023955A Medicine composition and use |
| 08/29/2007 | CN101023947A Methods and compositions for bactericide, bacteriostatic and anti-inflammation |
| 08/29/2007 | CN101023932A Coated granules containing ibuprofen |
| 08/29/2007 | CN101023772A Gastrodia-walnut health-care sweet |
| 08/29/2007 | CN101023769A Aloe air-conditioning tea |
| 08/29/2007 | CN101023765A Gastrodia tuber health-care tea |
| 08/29/2007 | CN100334091C Degraded triterpenes and their production method and use |
| 08/29/2007 | CN100333776C Chinese medicine composition for treating rheumatoid arthritis and its preparing method |
| 08/29/2007 | CN100333775C Chinese medicine for treating rheumatism |
| 08/29/2007 | CN100333762C Externally used medicine for curing acute or chronic soft tissue injury and process for preparing the same |
| 08/29/2007 | CN100333754C Pharmaceutical composition for treating fibrositis and its preparation and application |
| 08/29/2007 | CN100333752C Wind dispelling and bone benefiting conductive liquid |
| 08/29/2007 | CN100333734C Supramolecular extractive of creat, preparation method and application |
| 08/29/2007 | CN100333720C Compound analgesic agent |
| 08/28/2007 | US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1 |
| 08/28/2007 | US7262302 Antiinflammatory action; rheumatoid arthritis |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262274 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262193 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 08/28/2007 | US7262187 Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
| 08/28/2007 | US7262180 For therapy of dermatitis conditions and skin impairments such as atopic dermatitis, contact dermatitis, allergic contact dermatitis, allergic dermatitis, seborrheic dermatitis, nummular dermatitis, chronic dermatitis of hands or feet, generalized exfoliative dermatitis, stasis dermatitis |
| 08/28/2007 | US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit |
| 08/28/2007 | US7261891 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 08/28/2007 | CA2405072C Gel compositions containing metronidazole |
| 08/28/2007 | CA2257875C Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/28/2007 | CA2125763C P40 homodimer of interleukin-12 |
| 08/24/2007 | CA2579517A1 Ionized water and method of producing same |
| 08/23/2007 | WO2007095615A2 Use of benzo-heteroaryl sulfamide derivatives for the treatmentof pain |
| 08/23/2007 | WO2007095286A2 AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS |
| 08/23/2007 | WO2007095223A2 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 08/23/2007 | WO2007094669A2 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 08/23/2007 | WO2007094462A1 Non-human animal having modified genome or offspring thereof |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094193A1 Anti-angiogenic agent, prophylactic or therapeutic agent for disease accompanied by angiogenesis, and food |
| 08/23/2007 | WO2007093840A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
| 08/23/2007 | WO2007093601A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
| 08/23/2007 | WO2007093520A1 Hetero-bycyclic antiviral compounds |
| 08/23/2007 | WO2007093519A2 Ibandronate regimen for treating metastatic bone pain |
| 08/23/2007 | WO2007093387A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 08/23/2007 | WO2007093183A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 08/23/2007 | WO2007093027A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 08/23/2007 | WO2007077574A3 SULFOXIMINE DERIVATIVES AS p38 MAP KINASE INHIBITORS |
| 08/23/2007 | WO2007071456B1 Fluorenes and carbazoles as ligands of the ep2 receptor |
| 08/23/2007 | WO2007066068A3 Calcium ion channel receptor antagonist |
| 08/23/2007 | WO2007058894A3 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 08/23/2007 | WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
| 08/23/2007 | WO2006072823A8 Brachystemma calycinum preparation for joint pain |
| 08/23/2007 | WO2005035003A9 Compositions and methods for increasing drug efficiency |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | US20070197656 reducing pro-inflammatory response in diseased cell of respiratory tract by contacting cell with an agent that increases ceramide levels in cell thereby reducing pro-inflammatory response in cell, wherein agent is fenretinide and diseased cell is representative of disease state of cystic fibrosis |
| 08/23/2007 | US20070197644 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 08/23/2007 | US20070197603 Substituted indole ligands for the orl-1 receptor |
| 08/23/2007 | US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy |
| 08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
| 08/23/2007 | US20070197570 Indanol derivative |
| 08/23/2007 | US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |